HK1220413A1 - 预防胃肠梗阻的材料 - Google Patents

预防胃肠梗阻的材料 Download PDF

Info

Publication number
HK1220413A1
HK1220413A1 HK16108480.2A HK16108480A HK1220413A1 HK 1220413 A1 HK1220413 A1 HK 1220413A1 HK 16108480 A HK16108480 A HK 16108480A HK 1220413 A1 HK1220413 A1 HK 1220413A1
Authority
HK
Hong Kong
Prior art keywords
materials
gastrointestinal obstruction
obstruction prevention
peptide
amino acids
Prior art date
Application number
HK16108480.2A
Other languages
English (en)
Chinese (zh)
Inventor
Satoru Kobayashi
Toshio Uraoka
Naohisa Yahagi
Original Assignee
3-D Matrix, Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 3-D Matrix, Ltd. filed Critical 3-D Matrix, Ltd.
Publication of HK1220413A1 publication Critical patent/HK1220413A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/043—Proteins; Polypeptides; Degradation products thereof
    • A61L31/047—Other specific proteins or polypeptides not covered by A61L31/044 - A61L31/046
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/06—Flowable or injectable implant compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/22—Materials or treatment for tissue regeneration for reconstruction of hollow organs, e.g. bladder, esophagus, urether, uterus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Vascular Medicine (AREA)
  • Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dispersion Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK16108480.2A 2013-03-14 2014-03-13 预防胃肠梗阻的材料 HK1220413A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361785582P 2013-03-14 2013-03-14
US61/785,582 2013-03-14
PCT/IB2014/059748 WO2014141143A1 (en) 2013-03-14 2014-03-13 Materials for gastrointestinal obstruction prevention

Publications (1)

Publication Number Publication Date
HK1220413A1 true HK1220413A1 (zh) 2017-05-05

Family

ID=50424678

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16108480.2A HK1220413A1 (zh) 2013-03-14 2014-03-13 预防胃肠梗阻的材料

Country Status (10)

Country Link
US (1) US9724448B2 (https=)
EP (1) EP2968693B1 (https=)
JP (2) JP6478927B2 (https=)
KR (1) KR20160003651A (https=)
CN (1) CN105339020B (https=)
AU (1) AU2014229273B2 (https=)
BR (1) BR112015022747B1 (https=)
CA (1) CA2905182A1 (https=)
HK (1) HK1220413A1 (https=)
WO (1) WO2014141143A1 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101670099B1 (ko) 2008-10-06 2016-10-27 가부시끼가이샤 쓰리디 매트릭스 조직 폐색제
EP2869903B1 (en) 2012-07-06 2018-11-28 3-D Matrix Ltd. Fill-finish process for peptide solutions
WO2015136370A2 (en) 2014-03-10 2015-09-17 3-D Matrix, Ltd. Sterilization and filtration of peptide compositions
ES2712608T3 (es) 2014-03-10 2019-05-14 3 D Matrix Ltd Péptidos autoensamblantes para el tratamiento de las bullas pulmonares
AU2015229549B2 (en) * 2014-03-10 2019-05-23 3-D Matrix, Ltd. Self-assembling peptide compositions
US10814038B2 (en) 2016-01-06 2020-10-27 3-D Matrix, Ltd. Combination compositions
CN109996553A (zh) * 2016-06-27 2019-07-09 立美基股份有限公司 用于在内窥镜剥离术后预防食管狭窄的自组装肽基质
JP7012950B2 (ja) * 2016-11-17 2022-01-31 地方独立行政法人東京都立産業技術研究センター 生体組織孔閉鎖用、潰瘍保護用及び血管塞栓療術用ゾル
EP3818071A2 (en) 2018-07-03 2021-05-12 3-D Matrix, Ltd. Ionic self-assembling peptides
JP7437315B2 (ja) * 2018-10-05 2024-02-22 学校法人 久留米大学 腸管における潰瘍または瘻孔の治療または予防のための医薬組成物
ES2947713T3 (es) 2019-06-13 2023-08-17 Hollister Inc Productos de catéter urinario reutilizables
WO2020263859A1 (en) 2019-06-25 2020-12-30 Hollister Incorporated Reusable urinary catheter products
WO2021202577A1 (en) 2020-03-31 2021-10-07 3-D Matrix, Ltd. Sterilization of self-assembling peptides by irradiation
US20240252584A1 (en) * 2021-02-10 2024-08-01 3-D Matrix, Ltd. Pharmaceutical composition containing specific self-assembling peptide rada16 for treating or preventing lower gastrointestinal diseases such as inflammatory bowel disease

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0500643D0 (en) * 2005-01-13 2005-02-23 Renovo Ltd Medicaments
US9162005B2 (en) * 2005-04-25 2015-10-20 Arch Biosurgery, Inc. Compositions for prevention of adhesions and other barrier applications
JP5496671B2 (ja) * 2006-09-26 2014-05-21 マサチューセッツ インスティテュート オブ テクノロジー 修飾自己組織化ペプチド
EP2229960B1 (en) * 2007-12-05 2015-04-08 3-D Matrix, Ltd. Wound healing/skin reconstruction material
KR101670099B1 (ko) 2008-10-06 2016-10-27 가부시끼가이샤 쓰리디 매트릭스 조직 폐색제

Also Published As

Publication number Publication date
KR20160003651A (ko) 2016-01-11
US9724448B2 (en) 2017-08-08
JP6478927B2 (ja) 2019-03-06
WO2014141143A1 (en) 2014-09-18
CN105339020B (zh) 2020-06-16
AU2014229273B2 (en) 2016-12-01
EP2968693B1 (en) 2022-06-01
JP2016515113A (ja) 2016-05-26
BR112015022747B1 (pt) 2020-10-13
EP2968693A1 (en) 2016-01-20
CN105339020A (zh) 2016-02-17
AU2014229273A1 (en) 2015-10-08
BR112015022747A2 (pt) 2017-07-18
BR112015022747A8 (pt) 2019-12-03
CA2905182A1 (en) 2014-09-18
US20160000966A1 (en) 2016-01-07
JP2018115208A (ja) 2018-07-26

Similar Documents

Publication Publication Date Title
HK1220413A1 (zh) 预防胃肠梗阻的材料
IL262038B (en) Bicyclic heterocycles and pharmaceutical compositions thereof as inhibitors of one or more fgfr enzymes which are useful in the treatment of fgfr-related diseases
EP3337782A4 (en) DIACEREIN OR ITS ANALOGUE FOR INHIBITING THE EXPRESSION OF ASC, NLRP3 AND / OR FOR THE FORMATION OF NLRP3 INFLAMMASOM COMPLEX
ZA201808327B (en) Boronic acid derivatives and therapeutic uses thereof
CL2016002235A1 (es) Composiciones útiles en el tratamiento de deficiencia de ornitina-transcarbamilasa (otc)
EP3267994A4 (en) Methods for the treatment of nonalcoholic fatty liver disease and/or lipodystrophy
ZA201706929B (en) C1-inh compositions and methods for the prevention and treatment of disorders associated with c1 esterase inhibitor deficiency
HK1220145A1 (zh) 胆漏治疗
MX2016016832A (es) Materiales y metodos para llenar cavidades oseas.
EP3094718A4 (en) Microorganisms for the enhanced production of amino acids and related methods
DK2945642T3 (da) Faktor 1 protein til anvendelse i behandling eller forebyggelse af sygdomme
IL239330B (en) Triheptanoin for the treatment of glucose-1 transporter deficiency
EP3322420A4 (en) BICYCLIC HETEROCYCLES AS INHIBITORS OF THE CHOLESTERALESTER TRANSFER PROTEIN
SG11201706722YA (en) Acid composition based on leonardite and amino acids
EP3288961B8 (en) Short synthetic peptide for treating diseases and/or conditions related to angiogenesis
EP3101396A3 (en) Sensor to detect clogged drain in freeze/thaw applications
DK3250711T3 (da) Fremgangsmåde og produkt til at forhindre falske positiver i fremgangsmåder anvendende ddntp'er
EP3204767A4 (en) Utility of protein in the prediction of in vivo effects
EP2709455A4 (en) PROCESSES FOR THE PREPARATION OF 5-AZASPIRO [2.4] HEPTANE-6-CARBOXYLIC ACID AND ITS DERIVATIVES
EP3205661A4 (en) Hsp70-derived peptide, and method of manufacturing pharmaceutical composition, immunity inducer, and antigen-presenting cell for cancer treatment or prevention using the same
EP3201288A4 (en) Synthetic acid compositions alternatives to conventional acids in the oil and gas industry
EP3256455B8 (en) Method for the reduction of carboxylic acids or carbonic acid and their derivatives
SI3009133T1 (sl) Farmacevtski sestavek za uporabo pri zdravljenju ali preprečevanju vitaminsko-mineralnih pomanjkljivosti pri pacientih, ki so bili podvrženi želodčni by-pass-operaciji
FR3002414B1 (fr) Composition rodenticide sous forme de cereales et/ou de graines agglomerees.
EP3201290A4 (en) Synthetic acid compositions alternatives to conventional acids in the oil and gas industry